Literature DB >> 32363407

Screening of OXA-244 producers, a difficult-to-detect and emerging OXA-48 variant?

Cecile Emeraud1,2,3,4, Laura Biez2,4, Delphine Girlich2,4, Agnès B Jousset1,2,3,4, Thierry Naas1,2,3,4, Rémy A Bonnin2,3,4, Laurent Dortet1,2,3,4.   

Abstract

BACKGROUND: OXA-244, a single amino acid variant of OXA-48, demonstrates weaker hydrolytic activity towards carbapenems and temocillin compared with OXA-48. Of note, these antimicrobials are present in high concentrations in several carbapenemase-producing Enterobacterales (CPE) screening media. As a result, some screening media fail to grow OXA-244-producing isolates, while the prevalence of OXA-244 producers is constantly increasing in France.
METHODS: Here, we evaluate the performance of three commercially available CPE screening media [ChromID® CARBA SMART (bioMérieux), Brilliance™ CRE (Thermo Fisher) and mSuperCARBA™ (MAST Diagnostic)] for their ability to detect OXA-244 producers (n = 101). As OXA-244 producers may also express an ESBL, two additional ESBL screening media were tested (Brilliance™ ESBL and ChromID® BLSE). MICs of temocillin and imipenem were determined by broth microdilution. The clonality of OXA-244-producing Escherichia coli isolates (n = 97) was assessed by MLST.
RESULTS: Overall, the sensitivity of the ChromID® CARBA SMART, Brilliance™ CRE and mSuperCARBA™ media were 14% (95% CI = 8.1%-22.5%), 54% (95% CI = 43.3%-63.4%) and 99% (95% CI = 93.8%-100%), respectively, for the detection of OXA-244 producers. Among the 101 OXA-244-producing isolates, 96% were E. coli and 77%-78% grew on ESBL screening media. MLST analysis identified five main STs among OXA-244-producing E. coli isolates: ST38 (n = 37), ST361 (n = 17), ST69 (n = 12), ST167 (n = 11) and ST10 (n = 8).
CONCLUSIONS: Our results demonstrated that the mSuperCARBA™ medium is very efficient in the detection of OXA-244 producers, unlike the ChromID® CARBA SMART medium. The high prevalence of ESBLs among OXA-244 producers allowed detection of 77%-78% of them using ESBL-specific screening media.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32363407     DOI: 10.1093/jac/dkaa155

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  3 in total

1.  To Be or Not to Be an OXA-48 Carbapenemase.

Authors:  Laura Dabos; Saoussen Oueslati; Sandrine Bernabeu; Rémy A Bonnin; Laurent Dortet; Thierry Naas
Journal:  Microorganisms       Date:  2022-01-24

2.  Emergence and Polyclonal Dissemination of OXA-244-Producing Escherichia coli, France.

Authors:  Cecile Emeraud; Delphine Girlich; Rémy A Bonnin; Agnès B Jousset; Thierry Naas; Laurent Dortet
Journal:  Emerg Infect Dis       Date:  2021-04       Impact factor: 6.883

3.  Emergence of carbapenem-resistant ST131 Escherichia coli carrying bla OXA-244 in Germany, 2019 to 2020.

Authors:  Sybille Welker; Sébastien Boutin; Thomas Miethke; Klaus Heeg; Dennis Nurjadi
Journal:  Euro Surveill       Date:  2020-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.